Dr. Alexanian explains how he came to MD Anderson in 1964, then then talks about the evolution of his research, beginning with his experiences working on stem-cell kinetics while working with Dr. Laszlo Lajtha when he was on fellowship in Manchester, England. This focus enabled him to make the move to his second research fellowship in Seattle, where he worked with Dr. Clement Finch, a specialist in red cells, who taught him to focus on disease from a clinical perspective. Dr. Alexanian explains the skills he learned from these two mentors. He also notes that his experience enabled him to apply for grants for his own projects, and initiated work on erythropoietin. He describes his research and notes that he was the first person to measure no...
Interest in Cancer: Dr. Knudson continues outlining his path towards discovering the two-hit model. ...
To begin this segment, Dr. Rodriguez sketches her research while a Fellow at the University of Arizo...
In this chapter, begins to discuss his research contributions. He first notes that he met Dr. Judah...
Dr. Alexanian discusses his work with erythropoeinin and its impact. He then talks about how myeloma...
In this chapter, Dr. Dmitrovsky talks about the research project that would set him on the path to d...
In this chapter, Dr. Ahearn sketches his main contributions to pathology and the institution. First ...
In this chapter, Dr. Jones talks about the graduate research that brought him to MD Anderson. He sk...
Dr. DuBois begins this chapter by noting that in \u2779-\u2780 he had a vision of how basic sciences...
Dr. Dmitrovsky begins this chapter by noting that his successful study of DMSO and the c-Myk oncogen...
Dr. Freireich explains why the slow evolution of the blood separator made it necessary for him to le...
In this chapter, Dr. Elting talks about research studies she conducted just after receiving her DrPH...
In this chapter, Dr. Alexanian provides a snapshot of MD Anderson when he arrived in 1964. He explai...
Dr. Mills first tells how he was recruited to MD Anderson by Robert Bast, MD, VP of Translational Re...
Dr. Elting begins this chapter by explaining that the threat of infections was decreasing and so she...
In this chapter, Dr. DuBois explains that when he began college at Texas A & M University, he soon r...
Interest in Cancer: Dr. Knudson continues outlining his path towards discovering the two-hit model. ...
To begin this segment, Dr. Rodriguez sketches her research while a Fellow at the University of Arizo...
In this chapter, begins to discuss his research contributions. He first notes that he met Dr. Judah...
Dr. Alexanian discusses his work with erythropoeinin and its impact. He then talks about how myeloma...
In this chapter, Dr. Dmitrovsky talks about the research project that would set him on the path to d...
In this chapter, Dr. Ahearn sketches his main contributions to pathology and the institution. First ...
In this chapter, Dr. Jones talks about the graduate research that brought him to MD Anderson. He sk...
Dr. DuBois begins this chapter by noting that in \u2779-\u2780 he had a vision of how basic sciences...
Dr. Dmitrovsky begins this chapter by noting that his successful study of DMSO and the c-Myk oncogen...
Dr. Freireich explains why the slow evolution of the blood separator made it necessary for him to le...
In this chapter, Dr. Elting talks about research studies she conducted just after receiving her DrPH...
In this chapter, Dr. Alexanian provides a snapshot of MD Anderson when he arrived in 1964. He explai...
Dr. Mills first tells how he was recruited to MD Anderson by Robert Bast, MD, VP of Translational Re...
Dr. Elting begins this chapter by explaining that the threat of infections was decreasing and so she...
In this chapter, Dr. DuBois explains that when he began college at Texas A & M University, he soon r...
Interest in Cancer: Dr. Knudson continues outlining his path towards discovering the two-hit model. ...
To begin this segment, Dr. Rodriguez sketches her research while a Fellow at the University of Arizo...
In this chapter, begins to discuss his research contributions. He first notes that he met Dr. Judah...